tiprankstipranks
Advertisement
Advertisement
Teva reports Q2 EPS 2c, consensus 11c
PremiumThe FlyTeva reports Q2 EPS 2c, consensus 11c
6d ago
Teva backs FY26 EPS view $1.91-$2.11, consensus $2.16
Premium
The Fly
Teva backs FY26 EPS view $1.91-$2.11, consensus $2.16
6d ago
These Are the Stocks Reporting Earnings Today – July 29, 2026
Premium
Market News
These Are the Stocks Reporting Earnings Today – July 29, 2026
6d ago
Teva, Polpharma enter global licensing agreement for Ocrevus biosimilar
PremiumThe FlyTeva, Polpharma enter global licensing agreement for Ocrevus biosimilar
26d ago
Teva, Polpharma Biologics announce global licensing agreement
Premium
The Fly
Teva, Polpharma Biologics announce global licensing agreement
26d ago
Teva, Samsung Bioepis enter commercialization agreement for OPUVIZ
Premium
The Fly
Teva, Samsung Bioepis enter commercialization agreement for OPUVIZ
26d ago
Teva Buy Rating Reiterated as Pipeline Upside Supports Unchanged $42 Price Target
PremiumRatingsTeva Buy Rating Reiterated as Pipeline Upside Supports Unchanged $42 Price Target
1M ago
3 Best Healthcare Stocks to Buy in June, According to Analysts
Premium
Market News
3 Best Healthcare Stocks to Buy in June, According to Analysts
2M ago
Teva submits NDA for Ecopipam to FDA
Premium
The Fly
Teva submits NDA for Ecopipam to FDA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100